PIPORTIL L4 100 mg/4 ml, solution for injection IM in an ampoule ampoule, 4 ml
Active ingredients: Pipotiazine palmitate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionampoule, 4 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PIPORTIL L4 100 mg/4 ml, solution injectable IM en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 ampoule(s) en verre de 4 ml
- Marketing authorisation holder
- LABORATOIRES DELBERT
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Aug 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69069251CIP73140486CIP133400931404866Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PIPOTIAZINE (PALMITATE DE)solution | 100 mg · une ampoule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.